superbug mrsa

As Dr. LeRoy discussed in his previous blog post, the popularity of cosmetic surgery in India is quickly rising.  Unfortunately, according to reports published by The World Health Organization in August, so is the spread of the antibiotic resistant NDM-1 bacteria amongst the country’s cosmetic surgery patients.

Discovered initially amongst several British patients who developed infections after traveling to India or Pakistan to have cosmetic surgery, NDM-1 releases an enzyme which neutralizes the effective ingredients in most Western antibiotics.  New Delhi metallo-ß-lactamase-1, is of particular interest to US health officials because unlike most of the antibiotic resistant “superbugs” you hear about in American media (like MRSA,) NDM-1 bacteria develops easily within other bacteria regularly present in our bodies (therefore easily spread between patients.)

This announcement serves as another caution against the risks of “medical tourism” in which patients travel outside the US to have surgical procedures performed at discounted rates.  Dr. LeRoy reminds patients that while the financial advantage of discount procedures may be tempting in this economic crunch, it’s imperative to remember that one’s health is invaluable.

With the spread of NDM-1 bacteria into US patients, Dr. LeRoy also continues to stress the importance only entrusting board certified plastic surgeons that actively adhere to board standards for cleanliness and patient post-surgery care.

To learn more about the cosmetic facial, breast, and body procedures Dr. John LeRoy performs visit his website, contact his office, or subscribe to his blog.